View Article

  • Next-Gen Pharmacy: Opportunities and Challenges of AI from Research to patient care

  • 1Dr. D. Y Patil College of Pharmacy, Akurdi, Pune, Dr. D.Y. Patil Educational Complex, Sector No. 29, Pradhikaran, Akurdi. Pune, Maharashtra. India 411044

    2Assistant Professor, Dr D. Y. Patil College of Pharmacy, Akurdi, Pune, Dr. D.Y. Patil Educational Complex, Sector No. 29, Pradhikaran, Akurdi, Pune, Maharashtra, India 411044.,

Abstract

By bridging the gap between clinical practice and innovative research, artificial intelligence (AI) is revolutionizing healthcare. AI has shown great promise to improve speed, accuracy, and patient outcomes in a variety of fields, including diagnostics and personalized medicine. However, there are a number of technical, moral, and legal obstacles in the way of translating it from research settings to actual patient care. This paper examines the potential and difficulties of AI throughout the healthcare continuum, emphasizing implementation roadblocks and potential paths for secure and successful integration

Keywords

Ethics, Clinical Implementation, Machine Learning, Artificial Intelligence, Healthcare, and Patient Care.

Introduction

Artificial Intelligence (AI) is a field of computer science concerned with building intelligent machines and software programs that can perform human tasks, including learning, thinking, and solving problems. [1] While the pharma industry had already begun employing computers in the process of data collection and retail operations since the 1980s, the advent of AI has led to a paradigmatic shift in this sector.[2] Traditionally speaking, the working of the pharmacy system was always dependent on human thought and manual labor, thus leading to several drawbacks and limitations.[3]. While enhancing the accuracy of dispense drug, recurring tasks and data and optimizing patient counselling and new drug discovery is well executed by Modern AI [4] AI adoption in the pharmacy industry is varied and includes critical concepts such as personalized medicine, which entails the use of machine learning techniques to analyze very large amounts of patient data to tailor treatments according to need.[5] Moreover, AI adoption contributes immensely to improving patient safety through the detection of potential drug-to-drug interactions or disease-related adverse effects, while also making medicine stock management simpler through predictive analysis.[6] Also, AI technologies can be adopted through many AI applications such as virtual assistants to provide round-the-clock services.[7] Finally, the main reason behind integrating AI in the pharmacy business model is to enhance efficiency, accuracy, and effectiveness in patient care without compromising on cost-effectiveness.

Fig-1.1

Benefits

AI implementation into the pharmaceutical industry offers numerous advantages, including the following

  1. Enhanced Operational Efficiency and Cost Reduction: AI increases operational efficiency as a result of automation of many procedures associated with prescription processing, inventory management, and medicine dispensing. Automated technologies will reduce expenses involved in the operation not only of pharmacies but of the entire healthcare industry, avoiding potential delays due to human involvement.[8]
  2. Patient Safety: The use of AI minimizes errors that might be made due to the presence of algorithms designed to check dosages and to detect any potential interactions between medications as well as side effects.[9]
  3. Personalized Medicine: The AI system enables personalized medicine via algorithms capable of examining large data sets genetically. Technologies like CURATE.AI enable constant optimization of dosages.[10]
  4. Drug Development Acceleration: the drug discovery process can be accelerated by the Artificial intelligence technologies very efficiently. It also, suggests potential targets for drugs and even predicting their potency.Complex molecular analysis can be done with in few days or week using this type of AI technologies than years of hard work of humans [11]
  5. Increased Patient Involvement and Adherence to Medications: Patients would have access to 24/7 medication reminders and other relevant information through apps and chat-bots. This leads to improved adherence to medications and monitoring of chronic diseases using wearable.[12]
  6. Role of Pharmacists Evolved: With the use of AI technology, it becomes possible for pharmacists to focus more on patient consultations since all the administrative tasks have been computerized. Consequently, pharmacists can serve as health managers for their patients in the community.[13]

Role of AI in Health Care 

The use of Artificial Intelligence in the health sector will lead to a revolution that changes the way of handling things in the field. The reason is that AI can make the health sector move from a reactive approach to a more predictable, preventive, and personalized one.

The main roles of AI in health include:

  1. Medical Imaging and Diagnostics: This role involves the enhancement of diagnostic capabilities through AI's ability to scan images, including X-rays, CT, MRIs, and even detecting breast cancer, lung nodules, and pneumonia.[15]
  2. Monitoring of Patients and their Virtual Care: Personalized Medications and Treatments: The analysis of big data, genomics data, and patient records by AI helps to find an efficient and effective drug dose and treatment plan.[16]
  3. Personalized Medicine and Treatment: Personalized Medications and Treatments: The analysis of big data, genomics data, and patient records by AI helps to find an efficient and effective drug dose and treatment plan.[17]
  4. Pharmaceuticals Research: AI has proved to improve the process of drug discovery by using algorithms to detect drug targets and predict the success rate of novel drugs[18]
  5. Administrative Efficiency: AI helps automate repetitive processes such as stock maintenance, prescription generation, and nursing scheduling, thus enabling the healthcare staff to concentrate on patient care.[19]
  6. Health Population Management and Early Identification: The use of predictive analytics may help predict epidemics and at-risk populations, allowing for early intervention.[20]

Fig-1.2

Barriers/ Challenges to implementing AI in pharmacy practice

AI technology may encounter a number of obstacles that hinder its uptake, operation, and advancement, much like any other technology. Lack of awareness and understanding of AI applications in pharmacy could impede the adoption of AI technology. Data security and privacy issues are a significant obstacle to the deployment of AI technology. Since AI systems rely on the use of personal data to carry out necessary functions, they run the risk of violating patients' privacy and security even if AI has not yet achieved perfect privacy protection and safety. [21] The advent of AI technology in the workplace raises concerns about the potential loss of physical labour, since robots can execute regular activities more quickly, resulting in job schedule adjustments and the loss of employment in computational operations and costly human jobs. People are concerned about AI's ability to replace medical jobs, yet this viewpoint is based on a misunderstanding of AI's capabilities. AI's ability to replace medical professionals is dependent on its ability to adapt to unpredictable and human-factored medical treatments, rather than depending solely on algorithms. [22] Clinical professionals are accustomed to accepting accountability for their decisions; thus handling liability associated with the use of AI is particularly difficult. When AI is used to guide or even completely devolve decision-making, the problem gets more complicated, and issues about who or what is responsible for a poor outcome are common. The software developer who created the system, the vendor who sells the product, the healthcare service that bought it, the regulator who approved it, and the physicians who utilized the AI tool are all potential candidates. Due to the combination of the ethical and legal issues addressed, this problem is still unresolved, and healthcare practitioners are still accountable for their decisions, even if they are based on an AI algorithm for which they may have little or no knowledge.[23] Essentially, even though integrating AI requires significant initial financial and training investments, its wise application could result in operational efficiency, time-saving strategies, and significant cost savings. Furthermore, a major obstacle to AI operations in pharmacies is the lack of cooperation with other medical specialists. The whole spectrum of advantages of AI, including precise diagnosis and tailored therapy suggestions, cannot be realized without interdisciplinary cooperation. This restriction makes it more difficult to fully integrate AI into pharmacy operations and emphasizes how crucial it is to develop cooperative collaborations in order to optimize AI's advantages.[24] Health inequities could be made worse by AI systems that were trained on biased or non-representative datasets. Inaccurate dosage or improper treatment recommendations for minority groups, as well as misdiagnosis or misinterpretation of clinical data in under-represented communities, could result from this. By critically assessing AI-generated outputs, supporting inclusive and diverse data collection during model development, and encouraging fairness, transparency, and accountability in the deployment of AI technologies across healthcare settings, healthcare professionals play a critical role in mitigating such biases.[25] Even while AI has a lot of potential for use in clinical trials and pharmaceutical care, there are still a lot of obstacles in its way. First of all, one of the main obstacles to the use of AI in pharmacy is the data issue. Pharmaceutical data, which includes information from clinical trials, drug interactions, patient health records, and other sources, is varied, intricate, and expert. These data are frequently unstructured or semi-structured, which presents significant difficulties for data collection, storage, cleaning, and analysis and makes it challenging to use them directly for AI model training. Lastly, AI in the pharmacy industry faces issues related to career change and talent cultivation. The current pharmaceutical education system has not entirely adjusted to the need for chemists to possess new skills and knowledge, such as data analysis and algorithm principles, in order to apply AI technology.[26] In conclusion, despite artificial intelligence's great potential to revolutionize pharmacy practice, issues with data security, ethics, workforce preparedness, and system integration prevent it from being implemented successfully. To fully reap the benefits of AI in healthcare, these obstacles must be addressed through cooperation, education, and strong legal frameworks.

Future prospects of AI in pharmacy

1. Supply Chain Optimization: Predictive analytics is used to accurately predict pharmaceutical demand based on local health data and seasonal trends, allowing for automated restocking and lowering stock-outs.
Next-Generation Dispensing: Adding machine learning to Automated Dispensing Systems (ADSs) to forecast maintenance requirements and cross-referencing prescriptions with electronic health records (EHRs) to identify possible drug interactions or allergies.
Public health and equity: detecting socioeconomic inequities to develop customized healthcare programs for marginalized populations and using large-scale data to identify disease outbreaks early.

2. Digital Patient Engagement: Combining AI-driven chat-bots and virtual assistants with electronic health records (EHRs) to offer tailored prescription recommendations, reminders, and instructional materials to increase adherence.
Precision medicine is the process of creating customized treatment regimens to maximize therapeutic efficacy and reduce side effects by examining genetic information, medical history, and lifestyle factors.
Accelerated medication Development: It is anticipated that streamlining the process of finding therapeutic compounds and streamlining clinical trials will greatly cut down on the length of time and high expenses typically involved in medication research. [27]

3. Acceleration of Discovery Timelines: By identifying novel drug targets, designing optimised molecules, and predicting toxicity risks more quickly than traditional methods, AI-powered platforms are drastically reducing discovery timelines from years to months.

4. Drastic Cost Reduction: AI is being used to address the unsustainable economic reality of drug development, where costs frequently exceed $2 billion; it aims to reduce both time and expense in early-stage research.

5.    Personalized & Precision Medicine: By employing federated learning to safely analyse sensitive patient data and enhance the precision of clinical outcomes, AI will be essential in customizing medicines for each patient.

6.    Widespread Industrial Adoption: AI is being used more and more for supply chain management, drug safety monitoring, and industrial optimization by both major Indian companies and multinational pharmaceutical corporations.[28]

CONCLUSION
By increasing productivity, accuracy, and patient-centered care, artificial intelligence (AI) is revolutionizing the pharmacy industry. Personalized medicine, quicker medication discovery, and improved patient safety through improved monitoring and decision-making are all made possible by it. Despite its advantages, its adoption requires addressing issues including data security, ethical problems, and workforce adaption. To overcome these obstacles, cooperation among healthcare providers, appropriate training, and robust regulatory frameworks are crucial. AI has the potential to greatly enhance pharmacy practice and healthcare outcomes with continuing research and responsible application. AI is anticipated to further simplify pharmaceutical operations and lower total healthcare expenses in the future. In the end, its integration will help create a healthcare system that is more patient-centered, proactive, and predictive

REFERENCES

  1. Mak, K.-K. and M.R. Pichika, Artificial intelligence in drug development: present status and future prospects. Drug discovery today, 2019. 24(3): p. 773-780.
  2. Das, S., R. Dey, and A.K. Nayak, Artificial Intelligence in Pharmacy. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021. 55(2): p. 304-318.
  3. Deopujari, S., et al., Algoman: Gearing up for the “Net Generation” and Era of Artificial Intelligence, One Step at a Time. The Indian Journal of Pediatrics, 2019. 86(12): p. 1079-1080
  4. Honavar, V., Artificial intelligence: An overview. Artificial Intelligence Research Laboratory, 2006: p. 1-14.
  5. Shakya, S., Analysis of artificial intelligence-based image classification techniques. Journal of Innovative Image Processing (JIIP), 2020. 2(01): p. 44-54.
  6. Manikiran, S. and N. Prasanthi, Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma times, 2019. 51: p. 9-56a
  7. Musib, M., et al., Artificial intelligence in research. science, 2017. 357(6346): p. 28-30
  8. Allen Flynn. Using artificial intelligence in health-system pharmacy practice: finding new patterns that matter. Pharm.D., Ph.D Am J Health Syst Pharm. 2019;76(9): 622–627. https://doi.org/10.1093/ajhp/zxz018, 1 May
  9. Javaid M, Haleem A, Khan IH, Suman R. Understanding the potential applications of artificial intelligence in agriculture sector. Advanced Agrochem. 2023;2(1):15–30. https://doi.org/10.1016/j.aac.2022.10.001.
  10. Wani SUD, Khan NA, Thakur G, et al. Utilization of artificial intelligence in disease prevention: diagnosis, treatment, and implications for the healthcare workforce. Healthcare. 2022;10(4):608. https://doi.org/10.3390/healthcare10040608.
  11. Topol EJ. High-performance medicine: the convergence of human and Artificial Intelligence. Nat Med. 2019;25(1):44–56. https://doi.org/10.1038/ s41591-018-0300-7.
  12. Matheny ME, Whicher D, Thadaney Israni S. Artificial Intelligence in Health Care: a Report from the National Academy of Medicine. JAMA. 2020;323(6):509–10. https://doi.org/10.1001/jama.2019.21579.
  13. Russell SJ. Artificial intelligence a modern approach. Pearson Education, Inc.; 2010.
  14. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–8. https://doi.org/10.7861/futurehosp.6-2-94.
  15. Yersal O. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412–24. https://doi.org/10.5306/ wjco. v5.i3.412.
  16. Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med. 2023;388(13):1201–8. https://doi.org/10.1056/ NEJMra2302038.
  17. Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in health-care: past, present and future. Stroke Vasc Neurol. 2017;2(4):230–43. https:// doi.org/10.1136/svn-2017-000101
  18. Panch T, Szolovits P, Atun R. Artificial Intelligence, Machine Learning and Health Systems. J Global Health. 2018;8(2). https://doi.org/10.7189/ jogh.08.020303.

 

  1. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Preci-sion Medicine, AI, and the future of Personalized Health Care. Clin Transl Sci. 2021;14(1):86–93. https://doi.org/10.1111/cts.12884.
  2. Young AT, Amara D, Bhattacharya A, Wei ML. Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review. Lancet Digit Health. 2021;3(9):e599–e611. https://doi.org/10.1016/ S2589-7500(21)00132-1.
  3. Anan S. Jarab, Shrouq R. Abu Heshmeh & Ahmad Z. Al Meslamani, Artificial intelligence (AI) in pharmacy: An overview of innovations, Oct 2023, p. 1261-1263
  4. Md Ismail Ahamed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman, Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption, Volume 2, Issue 3, June 2024, p. 2-3
  5. Molla Imaduddin Ahmed, Brendan spooner, John Isherwood, Mark Lane, Emma Orrock, Ashley Denninson, A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare, 2023 Oct, p. 5-8
  6. Anan. S. Jarab, Artificial intelligence (AI) in pharmacy: an overview of innovation, 2023 Oct.
  7. Aftab Alam, Syed sikandar shah, Syed arman rabbani, Mohammed EI- Tanani, The Role of Artificial Intelligence in Pharmacy Practice and Patient Care: Innovations and Implications, Volume 5, issue 4, 2025 Nov, p. 16-18
  8. Ye Tian, Ye Wang, Ying Jiang, Yijia Luo, Yajun Chen, Application of AI in the field of pharmaceuticals care and drug clinical trials, January 2026
  9. Hesham Allam, Prescribing the future: The role of artificial intelligence in pharmacy, Volume 16, Issue 2, February 2025, p.6-13
  10. Bio-in-tech, AI Drug Discovery Startups: Key Player in 2026, February 2026.

Reference

  1. Mak, K.-K. and M.R. Pichika, Artificial intelligence in drug development: present status and future prospects. Drug discovery today, 2019. 24(3): p. 773-780.
  2. Das, S., R. Dey, and A.K. Nayak, Artificial Intelligence in Pharmacy. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2021. 55(2): p. 304-318.
  3. Deopujari, S., et al., Algoman: Gearing up for the “Net Generation” and Era of Artificial Intelligence, One Step at a Time. The Indian Journal of Pediatrics, 2019. 86(12): p. 1079-1080
  4. Honavar, V., Artificial intelligence: An overview. Artificial Intelligence Research Laboratory, 2006: p. 1-14.
  5. Shakya, S., Analysis of artificial intelligence-based image classification techniques. Journal of Innovative Image Processing (JIIP), 2020. 2(01): p. 44-54.
  6. Manikiran, S. and N. Prasanthi, Artificial Intelligence: Milestones and Role in Pharma and Healthcare Sector. Pharma times, 2019. 51: p. 9-56a
  7. Musib, M., et al., Artificial intelligence in research. science, 2017. 357(6346): p. 28-30
  8. Allen Flynn. Using artificial intelligence in health-system pharmacy practice: finding new patterns that matter. Pharm.D., Ph.D Am J Health Syst Pharm. 2019;76(9): 622–627. https://doi.org/10.1093/ajhp/zxz018, 1 May
  9. Javaid M, Haleem A, Khan IH, Suman R. Understanding the potential applications of artificial intelligence in agriculture sector. Advanced Agrochem. 2023;2(1):15–30. https://doi.org/10.1016/j.aac.2022.10.001.

 

  1. Wani SUD, Khan NA, Thakur G, et al. Utilization of artificial intelligence in disease prevention: diagnosis, treatment, and implications for the healthcare workforce. Healthcare. 2022;10(4):608. https://doi.org/10.3390/healthcare10040608.
  2. Topol EJ. High-performance medicine: the convergence of human and Artificial Intelligence. Nat Med. 2019;25(1):44–56. https://doi.org/10.1038/ s41591-018-0300-7.
  3. Matheny ME, Whicher D, Thadaney Israni S. Artificial Intelligence in Health Care: a Report from the National Academy of Medicine. JAMA. 2020;323(6):509–10. https://doi.org/10.1001/jama.2019.21579.
  4. Russell SJ. Artificial intelligence a modern approach. Pearson Education, Inc.; 2010.
  5. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–8. https://doi.org/10.7861/futurehosp.6-2-94.
  6. Yersal O. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412–24. https://doi.org/10.5306/ wjco. v5.i3.412.
  7. Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med. 2023;388(13):1201–8. https://doi.org/10.1056/ NEJMra2302038.
  8. Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, et al. Artificial intelligence in health-care: past, present and future. Stroke Vasc Neurol. 2017;2(4):230–43. https:// doi.org/10.1136/svn-2017-000101
  9. Panch T, Szolovits P, Atun R. Artificial Intelligence, Machine Learning and Health Systems. J Global Health. 2018;8(2). https://doi.org/10.7189/ jogh.08.020303.

 

  1. Johnson KB, Wei WQ, Weeraratne D, Frisse ME, Misulis K, Rhee K, et al. Preci-sion Medicine, AI, and the future of Personalized Health Care. Clin Transl Sci. 2021;14(1):86–93. https://doi.org/10.1111/cts.12884.
  2. Young AT, Amara D, Bhattacharya A, Wei ML. Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review. Lancet Digit Health. 2021;3(9):e599–e611. https://doi.org/10.1016/ S2589-7500(21)00132-1.
  3. Anan S. Jarab, Shrouq R. Abu Heshmeh & Ahmad Z. Al Meslamani, Artificial intelligence (AI) in pharmacy: An overview of innovations, Oct 2023, p. 1261-1263
  4. Md Ismail Ahamed Fahim, Tamanna Shahrin Tonny, Abdullah Al Noman, Realizing the potential of AI in pharmacy practice: Barriers and pathways to adoption, Volume 2, Issue 3, June 2024, p. 2-3
  5. Molla Imaduddin Ahmed, Brendan spooner, John Isherwood, Mark Lane, Emma Orrock, Ashley Denninson, A Systematic Review of the Barriers to the Implementation of Artificial Intelligence in Healthcare, 2023 Oct, p. 5-8
  6. Anan. S. Jarab, Artificial intelligence (AI) in pharmacy: an overview of innovation, 2023 Oct.
  7. Aftab Alam, Syed sikandar shah, Syed arman rabbani, Mohammed EI- Tanani, The Role of Artificial Intelligence in Pharmacy Practice and Patient Care: Innovations and Implications, Volume 5, issue 4, 2025 Nov, p. 16-18
  8. Ye Tian, Ye Wang, Ying Jiang, Yijia Luo, Yajun Chen, Application of AI in the field of pharmaceuticals care and drug clinical trials, January 2026
  9. Hesham Allam, Prescribing the future: The role of artificial intelligence in pharmacy, Volume 16, Issue 2, February 2025, p.6-13
  10. Bio-in-tech, AI Drug Discovery Startups: Key Player in 2026, February 2026.

Photo
Harshal Patil
Corresponding author

Dr. D. Y Patil College of Pharmacy, Akurdi, Pune, Dr. D.Y. Patil Educational Complex, Sector No. 29, Pradhikaran, Akurdi. Pune, Maharashtra. India 411044

Photo
Atharva Manish Kumar Singh
Co-author

Dr. D. Y Patil College of Pharmacy, Akurdi, Pune, Dr. D.Y. Patil Educational Complex, Sector No. 29, Pradhikaran, Akurdi. Pune, Maharashtra. India 411044

Photo
Kalyani Chande
Co-author

Assistant Professor, Dr D. Y. Patil College of Pharmacy, Akurdi, Pune, Dr. D.Y. Patil Educational Complex, Sector No. 29, Pradhikaran, Akurdi, Pune, Maharashtra, India 411044.,

Harshal Patil*, Atharva Manish Kumar Singh1, Kalyani Chande, Next-Gen Pharmacy: Opportunities and Challenges of AI from Research to patient care, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 2126-2133. https://doi.org/10.5281/zenodo.20099651

More related articles
Review on Phytochemical Profile of Adhatoda vasica...
Bhakti Khandagale, Prashant Palghadmal, Hindavi Adhav, Asmita Du...
The Impact of Pharmacovigilance on Patient Safety:...
Abhijeet Welankiwar, Anchal Kulte, Pradyumna Keche , ...
Formulation and Characterization of Herbal Tablets...
Ms. Aishwarya L. Thakur, Mr. Omkar P. Salunkhe, Ms. Sanchita N. P...
Related Articles
Phytochemical And Biological Screening of Tectona Grandis Leaves...
Satish Ponnada, Kiran Kumar Buralla, BhagyaLaxmi Suvvari, ...
Formulation And Evaluation Of Celecoxib Effervescent Tablet...
Gite Shriram Kisan , Gajare Asawari Sham, Garad Sakshi Sharad, Suhas S. Siddheshewar , ...
Review on Phytochemical Profile of Adhatoda vasica Leaves...
Bhakti Khandagale, Prashant Palghadmal, Hindavi Adhav, Asmita Dukre, Krishna Vishwasrao, Rajwardhan...
More related articles
Review on Phytochemical Profile of Adhatoda vasica Leaves...
Bhakti Khandagale, Prashant Palghadmal, Hindavi Adhav, Asmita Dukre, Krishna Vishwasrao, Rajwardhan...
The Impact of Pharmacovigilance on Patient Safety: A Comprehensive Review...
Abhijeet Welankiwar, Anchal Kulte, Pradyumna Keche , ...
Formulation and Characterization of Herbal Tablets for the Management of Anti-mi...
Ms. Aishwarya L. Thakur, Mr. Omkar P. Salunkhe, Ms. Sanchita N. Pednekar, Ms. Shruti C. Gawade, Ms. ...
Review on Phytochemical Profile of Adhatoda vasica Leaves...
Bhakti Khandagale, Prashant Palghadmal, Hindavi Adhav, Asmita Dukre, Krishna Vishwasrao, Rajwardhan...
The Impact of Pharmacovigilance on Patient Safety: A Comprehensive Review...
Abhijeet Welankiwar, Anchal Kulte, Pradyumna Keche , ...
Formulation and Characterization of Herbal Tablets for the Management of Anti-mi...
Ms. Aishwarya L. Thakur, Mr. Omkar P. Salunkhe, Ms. Sanchita N. Pednekar, Ms. Shruti C. Gawade, Ms. ...